212 related articles for article (PubMed ID: 25757734)
1. Lobular breast cancer: molecular basis, mouse and cellular models.
Christgen M; Derksen P
Breast Cancer Res; 2015 Feb; 17(1):16. PubMed ID: 25757734
[TBL] [Abstract][Full Text] [Related]
2. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
[TBL] [Abstract][Full Text] [Related]
3. mILC-ing the mouse mammary gland: A model for invasive lobular carcinoma.
Alvarez JV; Perez D; Chodosh LA
Cancer Cell; 2006 Nov; 10(5):347-9. PubMed ID: 17097555
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures.
Tasdemir N; Bossart EA; Li Z; Zhu L; Sikora MJ; Levine KM; Jacobsen BM; Tseng GC; Davidson NE; Oesterreich S
Cancer Res; 2018 Nov; 78(21):6209-6222. PubMed ID: 30228172
[TBL] [Abstract][Full Text] [Related]
5. PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.
Boelens MC; Nethe M; Klarenbeek S; de Ruiter JR; Schut E; Bonzanni N; Zeeman AL; Wientjens E; van der Burg E; Wessels L; van Amerongen R; Jonkers J
Cell Rep; 2016 Aug; 16(8):2087-2101. PubMed ID: 27524621
[TBL] [Abstract][Full Text] [Related]
6. Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.
Rätze MAK; Koorman T; Sijnesael T; Bassey-Archibong B; van de Ven R; Enserink L; Visser D; Jaksani S; Viciano I; Bakker ERM; Richard F; Tutt A; O'Leary L; Fitzpatrick A; Roca-Cusachs P; van Diest PJ; Desmedt C; Daniel JM; Isacke CM; Derksen PWB
Oncogene; 2022 May; 41(21):2932-2944. PubMed ID: 35437308
[TBL] [Abstract][Full Text] [Related]
7. Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors.
Nagle AM; Levine KM; Tasdemir N; Scott JA; Burlbaugh K; Kehm J; Katz TA; Boone DN; Jacobsen BM; Atkinson JM; Oesterreich S; Lee AV
Clin Cancer Res; 2018 Oct; 24(20):5165-5177. PubMed ID: 29941485
[No Abstract] [Full Text] [Related]
8. Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer.
Du T; Sikora MJ; Levine KM; Tasdemir N; Riggins RB; Wendell SG; Van Houten B; Oesterreich S
Breast Cancer Res; 2018 Sep; 20(1):106. PubMed ID: 30180878
[TBL] [Abstract][Full Text] [Related]
9. Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.
Hollestelle A; Elstrodt F; Timmermans M; Sieuwerts AM; Klijn JG; Foekens JA; den Bakker MA; Schutte M
Breast Cancer Res Treat; 2010 Jul; 122(1):125-33. PubMed ID: 19763817
[TBL] [Abstract][Full Text] [Related]
10. p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice.
Tenhagen M; Klarenbeek S; Braumuller TM; Hofmann I; van der Groep P; Ter Hoeve N; van der Wall E; Jonkers J; Derksen PW
J Mammary Gland Biol Neoplasia; 2016 Dec; 21(3-4):81-88. PubMed ID: 27411687
[TBL] [Abstract][Full Text] [Related]
11. Malignant phyllodes tumor and invasive lobular breast carcinoma: Morpho-molecular characterization of an uncommon collision tumor and review of the literature.
Schaumann N; Bartels S; Kuehnle E; Kreipe H; Christgen M
Pathol Res Pract; 2024 Feb; 254():155100. PubMed ID: 38277744
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
13. Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms.
Schipper K; Drenth AP; van der Burg E; Cornelissen S; Klarenbeek S; Nethe M; Jonkers J
Cancer Res; 2020 Apr; 80(7):1486-1497. PubMed ID: 32060147
[TBL] [Abstract][Full Text] [Related]
14. Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice.
Derksen PW; Braumuller TM; van der Burg E; Hornsveld M; Mesman E; Wesseling J; Krimpenfort P; Jonkers J
Dis Model Mech; 2011 May; 4(3):347-58. PubMed ID: 21282721
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer.
Christgen M; Bruchhardt H; Hadamitzky C; Rudolph C; Steinemann D; Gadzicki D; Hasemeier B; Römermann D; Focken T; Krech T; Ballmaier M; Schlegelberger B; Kreipe H; Lehmann U
J Pathol; 2009 Apr; 217(5):620-32. PubMed ID: 19191266
[TBL] [Abstract][Full Text] [Related]
16. Loss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast Carcinoma.
Elangovan A; Hooda J; Savariau L; Puthanmadhomnarayanan S; Yates ME; Chen J; Brown DD; McAuliffe PF; Oesterreich S; Atkinson JM; Lee AV
Mol Cancer Res; 2022 Sep; 20(9):1405-1419. PubMed ID: 35665642
[TBL] [Abstract][Full Text] [Related]
17. Invasive lobular carcinoma of the breast: patient response to systemic endocrine therapy and hormone response in model systems.
Sikora MJ; Jankowitz RC; Dabbs DJ; Oesterreich S
Steroids; 2013 Jun; 78(6):568-75. PubMed ID: 23178159
[TBL] [Abstract][Full Text] [Related]
18. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.
Derksen PW; Liu X; Saridin F; van der Gulden H; Zevenhoven J; Evers B; van Beijnum JR; Griffioen AW; Vink J; Krimpenfort P; Peterse JL; Cardiff RD; Berns A; Jonkers J
Cancer Cell; 2006 Nov; 10(5):437-49. PubMed ID: 17097565
[TBL] [Abstract][Full Text] [Related]
19. CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast.
Mercapide J; Zhang SY; Fan X; Furió-Bacete V; Schneider J; López de la Osa I; Patchefsky AS; Klein-Szanto AJ; Castresana JS
Mol Carcinog; 2002 Sep; 35(1):6-12. PubMed ID: 12203362
[TBL] [Abstract][Full Text] [Related]
20. Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland.
Annunziato S; Kas SM; Nethe M; Yücel H; Del Bravo J; Pritchard C; Bin Ali R; van Gerwen B; Siteur B; Drenth AP; Schut E; van de Ven M; Boelens MC; Klarenbeek S; Huijbers IJ; van Miltenburg MH; Jonkers J
Genes Dev; 2016 Jun; 30(12):1470-80. PubMed ID: 27340177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]